Ask AI
ProCE Banner Activity

ExpressPoints: The Evolution of Antibody–Drug Conjugates in Breast Cancer

Slideset Download

Download this short summary slideset of key takeaway points from a live presentation on new developments with antibody-drug conjugates in breast cancer.

Released: November 03, 2020

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.

Faculty Disclosure

Primary Author

Javier Cortes, MD, PhD

International Breast Cancer Center (IBCC), Pangea Oncology, Quiron Group
Barcelona, Spain
IOB Madrid, Institute of Oncology
Hospital Beata María Ana
Madrid, Spain

Javier Cortes, MD, PhD: consultant/advisor: AbbVie, AstraZeneca, Bioasis, BioInvent, Biocon, BioNtech, Bliss, Boehringer Ingelheim, BridgeBio, Circle, Clovis Oncology, Daiichi Sankyo, Delcath Systems, Ellipses, Expres2ion, Gemoab, Gilead, Hexagon Bio, HiberCell, Jazz, Leuko, Lilly, Menarini, Merck Sharp & Dohme, Relay, Reveal Genomics, Roche, Scorpion, Seattle Genetics, Zymeworks; researcher (paid to institution): Aria, AstraZeneca, Bayer Healthcare, Baxalta GmbH/Servier Affaires, Eisai, F. Hoffmann-La Roche, Guardant Health, Merck Sharp & Dohme, Pfizer, Piqure, Roche; other material or financial support: AstraZeneca, Daiichi Sankyo, Esiai, Gilead, Lilly, Merck Sharp & Dohme, Novartis, Pfizer, Roche, Stemline, Zuellig; royalties or patent beneficiary: issued patent: pharmaceutical combinations of a PI3K inhibitor and a microtubule destabilizing agent (WO 2014/199294 A), licensed patent: HER2 as a predictor of response to dual HER2 blockade in the absence of cytotoxic therapy (US 2019/0338368 A1); stock: Leuko.

Ian Krop, MD, PhD

Professor of Internal Medicine
Associate Cancer Center Director for Clinical Research
Chief Clinical Research Officer
Yale Cancer Center
New Haven, Connecticut

Ian Krop, MD, PhD: consultant/advisor/speaker: ALX Oncology, AstraZeneca, Daiichi Sankyo, EMD Serono, Genentech/Roche, Novartis, Ottimo, Pfizer, Seagen.

Prof Michael Untch, MD, PhD

Director of the Clinic
Gynecology, Gyencologic Oncology and Obstetrics
Helios Hospital Berlin-Buch
Berlin, Germany